These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3515812)

  • 1. [Basic results of a committee trial of the new vaccine Grippovac SE-AZh].
    Bashliaeva ZA; Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Ozeretskovskaia NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):49-54. PubMed ID: 3515812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunogenicity and the protective effectiveness of the subunit trivalent influenza vaccine Grippovac].
    Chumakov MP; Malyshkina LP; Mart'ianova LI; Marinina VP; Mel'nikova SK
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):44-9. PubMed ID: 2938372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984].
    Chumakov MP; Boĭko VM; Malyshkina LP; Mel'nikova SK; Rodin VI
    Vopr Virusol; 1987; 32(2):175-83. PubMed ID: 3300032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults).
    Rudenko LG; Zykov MP; Romanov YuA ; Zakharov NG; Leonov VM; Melnikova SK; Chumakov MP
    Acta Virol; 1985 May; 29(3):237-41. PubMed ID: 2864825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 6. [The results of state trials of inactivated influenza vaccines for children].
    Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime].
    Vasil'eva RI; Liamtseva GA; Riazantseva TG; Oleĭnikova EV; Sosunov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):10-4. PubMed ID: 2939666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evaluation of the reactogenicity and immunological activity of an inactivated 3-component influenza vaccine with an elevated hemagglutinin concentration in the inoculation dosage].
    Marinich IG; Shadrin AS; Naĭkhin AN; Ivannikov IuG; Kuznetsov NP; Karogodina VI; Shcherbinskaia AM; Voronina EG; Stepankovskaia LD; Eliseeva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):58-61. PubMed ID: 1950267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of a study of new preparations of inactivated whole-virion influenza vaccines for the protection of children in the USSR].
    Vasil'eva RI; Lonskaia NI; Nefedova LA; Iaroshevskaia IIu; Bichurina MA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):38-42. PubMed ID: 3591124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].
    El'shina GA; Gorbunov MA; Bektimirov TA; Lonskaia NI; Pavlova LI; Nikul'shin AA; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):50-4. PubMed ID: 10808574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14].
    Rudenko LG; Ramirez A; Barro M; Gushchina MI; Armanda RE; Ermachenko TA; Romanova IuR; Grigor'eva EP; Aleksandrova GI; Lonskaia NI
    Vopr Virusol; 1991; 36(6):472-4. PubMed ID: 1785181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old].
    Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI
    Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.